In this episode of the Prohormone Podcast I talk about the newly launched Blackstone Labs product called EpiCat. EpiCat is an epicatechin supplement believed to inhibit myostatin.
- Why I was so down on the first epicatechin supplements to hit the market (my epicatechin hate)
- Why the first study on the follistatin, epicatechin relationship was not convincing enough for me to purchase any epicatechin supplements
- What is myostatin, and why is it bad
- The myostatin deficient baby (details here – myostatin deficiency)
- What is follistatin, and why is it good
- Why three different drug companies are exploring the components of dark chocolate (including epicatechin)
- The new study by Cardero Therapeutics including the half life, and bioavialability of epicatechin
- Did epicatechin increase follistatin, and if so how much, and was it enough to matter?
- Epicatechin and nitric oxide
- Is EpiCat worth the price?
References and additional reading:
- Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (-)-epicatechin in healthy volunteers
- Everything you ever wanted to know about Myostatin – The role of myostatin in muscle wasting: an overview
- Supplemental data to the Pharmacokinetic study on epicatechin – Supplemental data
- EpiCat at Blackstone Labs – EpiCat
- A graph and table from the full text showing plasma levels and pharmacodynamics: